The nanoplatform enabled anti-HER2 antibodies to be stably expressed on the macrophage membrane (HM), making it more effective against HER2+ tumor cells, achieving precise targeted delivery of near-infrared (NIR) fluorescent dye IR780 or chemotherapy drugs GEM. The gene discussed is ERBB2; the disease is neoplasm.